Yi Kai Sit
Lawyers
Filters
Beisen Holding HK$155 million IPO
We advised Beisen on its IPO and HKEX listing
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement
InnoCare Pharma RMB2.9 billion Shanghai IPO
This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far